CSIMarket


Icad Inc  (ICAD)
Other Ticker:  
 


 

Icad Inc

ICAD's Financial Statements and Analysis



Icad Inc narrowed first quarter of 2024 net loss per share of $-0.05 compare to net loss per share of $-0.15 recorded in the same quarter a year ago a decrease from $0.08 eps realized in IV. Quarter (Dec 31 2023).


first quarter of 2024
Earnings Per Share Revenues
$ -0.05 $  5 Mill
$+0.10     $-1M     -14.26 %



Icad Inc's Revenue fell by -14.26 % in first quarter of 2024 (Mar 31 2024) year on year, to $5 million and advanced by 212.56 % sequentially.


Icad Inc is

More on ICAD's Income Statement



Icad Inc in the first quarter of 2024 recorded net loss of $-1.222 million, an improvement compare to net loss of $-3.778 million in I. Quarter a year ago.

Sequentially company realized a net loss, compared to net income of $2.055 million in the previous quarter.

More on ICAD's Growth

Icad Inc Inventories
Inventories declined by -84.59 % to $0.75 million from I. Quarter a year ago, sequentially inventories fell by -18.21 %. In Mar 31 2024 company's net cash and cash equivalents decreased by $-1 million, capital expenditures fell by -0.12268.85%, to $0 millions compare to same quarter a year ago

More on ICAD's Cash flow Statement


Icad Inc does not pay out common stock dividend.

In trailing twelve-month period Icad Inc payed $ -0.18 cash per share, on a free-cash flow basis .

Book value fell by -5.97 % sequentially to $1.23 per share, -83.84% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.91 per share from $ 0.98.

Company issued 0.84 million shares or 3.31 % in Mar 31 2024.


More on ICAD's Dividends

 Market Capitalization (Millions) 42
 Shares Outstanding (Millions) 26
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 16
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Icad Inc does not pay out common stock dividend.

In trailing twelve-month period Icad Inc had negative $ -0.18 cash flow per share, on a free-cash flow basis .

Book value fell by -5.97 % sequentially to $1.23 per share, -83.84% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.91 per share from $ 0.98.

Company issued 0.84 million shares or 3.31 % in Mar 31 2024.


More on ICAD's Balance Sheets

 Market Capitalization (Millions) 42
 Shares Outstanding (Millions) 26
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 16
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Icad Inc Earnings

Icad Inc Reports Loss on Weak Sales in Financial Interval Closing Mar 31, 20242.

Icad Inc, a global leader in AI-powered breast health solutions, has recently reported its financial and operating results for the three months ended March 31, 2024. The company showcased its ProFound Breast Health Suite of AI solutions at the Society for Breast Imaging annual symposium, including the highly anticipated ProFound Cloud, powered by Google Cloud and Google Health AI architecture. Additionally, iCAD's strategic partnership with Densitas aims to enhance and optimize breast cancer diagnostics, ultimately benefiting healthcare professionals and patients alike.
Despite these promising developments, Icad Inc has experienced some fluctuations in its stock performance. While the stock recorded a so...

Shockingly Sudden: Icad Inc Faces Dramatic Decline in Fourth Quarter of 2023

iCAD, Inc. is a company making significant stri...

Icad Inc: Reigniting Revenue Growth in the Third Quarter of 2023


By
As an investor closely following the latest financial developments, I am always on the lookout for companies that exhibit resilience and strategic growth potential. One such company that has captured my attention is Icad Inc. Despite the challenges posed by the economic climate, their recent financial results for the third quarter of 2023 have showcased some positive trends.
First and foremost, let us address the bottom line. Icad has managed to significantly reduce its loss per share, recording a decrease from $-0.15 per share a year prior to $-0.05 per share. Moreover, their third-quarter EPS improved from $-0.07 per share in the previous quarter. This emphasizes the company's commitment t...

Icad Inc's Financial Report Reveals Significant Improvement in Profitability and Income per Share for the Period Ending June 30, 2023

Icad Inc: A Financial Overview
Icad Inc, a company specializing in a particular industry, has recently released its financial report for the period ending June 30, 2023. This report provides valuable insights into the company's performance and highlights key financial indicators that investors and analysts can use to evaluate the company's stability and growth potential.
One of the key highlights of the report is the decrease in the company's loss per share. Over the past year, Icad Inc has managed to reduce its loss per share from $-0.12 to $-0.07, indicating an improvement in its profitability. Additionally, the company has seen an improvement in its income per share, rising from $-0.15 per share i...

ICAD's First Quarter of 2023 Earnings Season Indicates Worsening Diminishing Returns

ICAD Inc., a leader in cancer de...


Date modified: 2024-05-15T23:06:26+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com